Abstract Details

Title In vivo Safety and Efficacy of a 3rd generation Antisense Oligonucleotide targetting TGF-ßRII to treat Amyotrophic Lateralsclerosis

Topic General Neurology

Presentation(s) P1 - (-)

Poster/Presentation
Number 325

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
Sabrina Kuespert, PhD (University Hospital Regensburg)	No disclosure on file
	No disclosure on file
	No disclosure on file
Tim-Henrik Bruun, PhD (University Hospital Regensburg)	No disclosure on file
Ulrich Bogdahn, MD (University Hospital Regensburg)	No disclosure on file